We are live on ! Find out more
AIA

AIMZ Investment Advisors Portfolio holdings

AUM $324M
1-Year Est. Return 18.77%
This Fund
S&P 500
This Quarter Est. Return
+11.24%
1 Year Est. Return
+18.77%
3 Year Est. Return
+63.89%
5 Year Est. Return
+85.69%
10 Year Est. Return
+323.28%
AUM
$247M
AUM Growth
+$22M
Cap. Flow
-$1.09M
Cap. Flow %
-0.44%
Top 10 Hldgs %
37.05%
Holding
117
New
5
Increased
13
Reduced
63
Closed
3

Top Buys

Rank Stock Value
1
EEFT icon
Euronet Worldwide
EEFT
+$1.96M
2
PYPL icon
PayPal
PYPL
+$226K
3
TROW icon
T. Rowe Price
TROW
+$223K
4
SPR
Spirit AeroSystems
SPR
+$216K
5
ALL icon
Allstate
ALL
+$209K

Sector Composition

Rank Sector Weight
1 Technology 32.39%
2 Healthcare 28.23%
3 Industrials 10.07%
4 Communication Services 7.65%
5 Financials 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.95T
$17.9M 7.26%
93,098
-1,930
-2% -$356K
MSFT icon
2
Microsoft
MSFT
$2.89T
$12M 4.85%
31,842
-1,374
-4% -$489K
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$10.9M 4.43%
30,918
-184
-0.6% -$59.9K
REGN icon
4
Regeneron Pharmaceuticals
REGN
$69.9B
$9.17M 3.71%
10,439
-171
-2% -$141K
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$122B
$9.07M 3.67%
22,291
-265
-1% -$97.9K
QCOM icon
6
Qualcomm
QCOM
$179B
$9.07M 3.67%
62,684
-530
-0.8% -$65.6K
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.99T
$6.15M 2.49%
44,061
-351
-0.8% -$47.2K
INFY icon
8
Infosys
INFY
$47.4B
$5.96M 2.41%
324,008
-1,119
-0.3% -$19.5K
GILD icon
9
Gilead Sciences
GILD
$162B
$5.62M 2.28%
69,436
-1,038
-1% -$80.8K
NTAP icon
10
NetApp
NTAP
$33.3B
$5.57M 2.26%
63,229
-440
-0.7% -$35.4K
TROW icon
11
T. Rowe Price
TROW
$25.5B
$5.19M 2.1%
48,150
+2,236
+5% +$223K
EXPD icon
12
Expeditors International
EXPD
$22.4B
$5.11M 2.07%
40,158
-712
-2% -$84K
CTAS icon
13
Cintas
CTAS
$84.4B
$4.5M 1.82%
29,888
-500
-2% -$67K
AMGN icon
14
Amgen
AMGN
$203B
$4.07M 1.65%
14,115
-156
-1% -$42.5K
BRK.B icon
15
Berkshire Hathaway Class B
BRK.B
$1.07T
$4.06M 1.65%
11,397
-100
-0.9% -$35.1K
AZN icon
16
AstraZeneca
AZN
$263B
$4.04M 1.64%
30,027
-531
-2% -$69K
INCY icon
17
Incyte
INCY
$23.7B
$3.93M 1.59%
62,561
-501
-0.8% -$28.3K
ADBE icon
18
Adobe
ADBE
$94.5B
$3.88M 1.57%
6,499
-31
-0.5% -$17.9K
CHRW icon
19
C.H. Robinson
CHRW
$20.6B
$3.81M 1.54%
44,056
-611
-1% -$51.2K
CHKP icon
20
Check Point Software Technologies
CHKP
$13.6B
$3.77M 1.53%
24,664
-300
-1% -$42.4K
CSCO icon
21
Cisco
CSCO
$452B
$3.72M 1.51%
73,536
-793
-1% -$40.5K
PYPL icon
22
PayPal
PYPL
$49.5B
$3.46M 1.4%
56,262
+3,950
+8% +$226K
IBM icon
23
IBM
IBM
$204B
$3.15M 1.28%
19,279
-97
-0.5% -$14.7K
UNH icon
24
UnitedHealth
UNH
$379B
$3.15M 1.28%
5,989
-54
-0.9% -$28.8K
MRK icon
25
Merck
MRK
$323B
$3.08M 1.25%
28,292
-168
-0.6% -$17.4K

Similar funds

AIMZ Investment Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, AIMZ Investment Advisors held 117 positions worth $247M, up 9.8% from $225M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

AIMZ Investment Advisors's Q4 2023 filing shows 5 new, 13 increased, 63 reduced and 3 closed positions. Its largest new stake was Euronet Worldwide: 22,925 shares worth $2.33M. The largest sale was NextGen Healthcare, Inc. Common Stock, an estimated $894K.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.

  • AIMZ Investment Advisors's largest Q4 2023 buy was Euronet Worldwide: 22,925 shares worth $2.33M.
  • AIMZ Investment Advisors added most to PayPal in Q4 2023, an estimated $226K increase.
  • AIMZ Investment Advisors's biggest Q4 2023 reduction was Microsoft, cutting an estimated $489K.
  • AIMZ Investment Advisors fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $894K.
  • AIMZ Investment Advisors's ten largest holdings make up 37% of its $247M portfolio in Q4 2023.
  • AIMZ Investment Advisors opened 5 new positions and closed 3 in Q4 2023.
  • AIMZ Investment Advisors's portfolio value rose 9.8% quarter-over-quarter to $247M.

Based on AIMZ Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.